| LncRNAs | Disease | Experimental methods | Regulated | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Pubmed ID | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LINC00514 | papillary thyroid cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 30553447 | 2018 |
| LINC00514 | neuroendocrine prostate cancer | RNA-seq, Microarray, qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | 29757368 | 2018 |
| LINC00514 | Triple negative breast cancer | qPCR;RT-qPCR;Flow Cytometry assay;Luciferase reporter assay;Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33757509 | 2021 |
| LINC00514 | Gastric cancer | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | 33888645 | 2021 |